A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country

BACKGROUND: Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the pattern of use of SGLT2is compared to other oral antidiabetic drugs in the Middle East, including Qatar. AIM: This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaghloul, Nancy, Awaisu, Ahmed, Mahfouz, Ahmed, Alyafei, Sumaya, Elewa, Hazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718883/
https://www.ncbi.nlm.nih.gov/pubmed/36169802
http://dx.doi.org/10.1007/s11096-022-01464-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718883/
https://www.ncbi.nlm.nih.gov/pubmed/36169802
http://dx.doi.org/10.1007/s11096-022-01464-x

Ejemplares similares